Egyptian hospitals uncover rare kidney disease patterns

NCT ID NCT07218536

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times

Summary

This study looks back at the medical records of 200 people in Egypt diagnosed with atypical hemolytic uremic syndrome (aHUS), a rare and serious disease that can damage the kidneys and other organs. Researchers want to learn more about the patients' characteristics, how the disease progresses, and what treatments are currently used in Egypt. The goal is to improve early diagnosis and care for this condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATYPICAL HEMOLYTIC UREMIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
NOT_YET_RECRUITING

Al Mansurah, Egypt
Research Site
RECRUITING

Alexandria, Egypt
Research Site
RECRUITING

Asyut, Egypt
Research Site
RECRUITING

Cairo, Egypt
Research Site
NOT_YET_RECRUITING

New Cairo, Egypt
Research Site
RECRUITING

New Cairo, Egypt
Research Site
RECRUITING

Tanta, Egypt
Research Site
RECRUITING

Zagazig, Egypt

Conditions

Explore the condition pages connected to this study.

ATYPICAL HEMOLYTIC UREMIC SYNDROME